Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”-Reference-Cited by-同舟云学术

Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”

Published:2021-05-19 Issue: Volume: Page:1-3
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Gómez Jorge A.¹^ORCID,Pinto Thatiana de Jesus Pereira²,Guevara Javier Nieto³,Noronha Tatiana Guimarães de⁴

Affiliation:

1. Vaccine Department, GlaxoSmithKline, Buenos Aires, Argentina

2. Vaccine Department, GlaxoSmithKline, Rio de Janeiro, Brazil

3. Vaccine Department, GlaxoSmithKline, Panama City, Panama

4. Institute of Technology for Immunobiologicals of Bio-Manguinhos, FIOCRUZ, Rio de Janeiro, Brazil

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1894898

Reference14 articles.

1. Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants

2. Ministry of Health. Informatics department of the Brazilian unified health system. DATASUS web page. 2020. [accessed 2020 Dec 20]. https://datasus.saude.gov.br/informacoes-de-saude-tabnet/.

3. Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia

4. Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil

5. Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil